Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer
ClinicalTrials.gov study NCT02907918. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
ClinicalTrials.gov study NCT02954536. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Eribulin in HER2 Negative Metastatic BrCa
ClinicalTrials.gov study NCT01827787. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
ClinicalTrials.gov study NCT01008150. IPD Sharing: Not stated. Countries: 5. Publications: 2.
A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progress
ClinicalTrials.gov study NCT02536339. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT01086605. IPD Sharing: Not stated. Countries: 1. Publications: 1.
To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)
ClinicalTrials.gov study NCT03644186. IPD Sharing: NO. Countries: 4. Publications: 14.
Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT01705691. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients
ClinicalTrials.gov study NCT00841828. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification
ClinicalTrials.gov study NCT02177175. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT02236000. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Meta
ClinicalTrials.gov study NCT02069093. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Towards establishing extracellular vesicle-associated RNAs as biomarkers for HER2+ breast cancer
<p class="Abstract">Extracellular vesicles (EVs) are emerging as key players in breast cancer progression and hold immense promise as cancer biomarkers. However, difficulties in obtaining sufficient quantities of EVs for the identification of potential biomarkers hampers progress in this area. To circumvent this obstacle, we cultured BT-474 breast cancer cells in a two-chambered bioreactor with CDM-HD serum replacement to significantly improve the yield of cancer cell-associated EVs and eliminate bovine EV contamination. Cancer-relevant mRNAs <i>BIRC5 </i>(Survivin) and <i>YBX1</i>,<i> </i>as well as long-noncoding RNAs <i>HOTAIR</i>, <i>ZFAS1</i>, and <i>AGAP2-AS1 </i>were detected in BT-474 EVs by quantitative RT-PCR. Bioinformatics meta-analyses showed that <i>BIRC5 </i>and <i>HOTAIR </i>RNAs were substantially upregulated in breast tumours compared to non-tumour breast tissue, warranting further studies to explore their usefulness as biomarkers in patient EV samples. We envision this effective procedure for obtaining large amounts of cancer-specific EVs will accelerate discovery of EV-associated RNA biomarkers for cancers including HER2+ breast cancer.</p>
HER2 RNA Molecular Simulation Data
<p>This is a data file for the HER2 RNA molecular simulation research by Arli Aditya Parikesit. More on me, please kindly check this link: orcid.org/0000-0001-8716-3926 </p>
Data and Code for "Genomic mechanisms of resistance to tyrosine kinase inhibitors in HER2 amplified breast cancer"; Parsons et al. 2024
<p>Data and code for the manuscript <em>Genomic mechanisms of resistance to tyrosine kinase inhibitors in HER2 amplified breast cancer</em> (Parsons et al. 2024).</p> <p>Data: `parsons_her2_tki_data.tar.gz`</p> <p>Code: `parsons_her2_tki_code.tar.gz`</p> <p>The code may also be obtained from our GitHub repository:<br>https://github.com/getzlab/parsons_her2_tki_manuscript<br><br><br></p>
A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Pr
ClinicalTrials.gov study NCT04147819. IPD Sharing: NO. Countries: 2. Publications: 1.
Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer. (PHOEBE)
ClinicalTrials.gov study NCT03080805. IPD Sharing: NO. Countries: 1. Publications: 2.
Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors
ClinicalTrials.gov study NCT04521179. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer
ClinicalTrials.gov study NCT00773695. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.
ClinicalTrials.gov study NCT04681287. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.